Alfonso Berrocal J.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
- A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study of Adjuvant MK-7684A (Vibostolimab with Pembrolizumab) Versus Adjuvant Pembrolizumab in Participants with High-risk Stage II-IV Melanoma (KEYVIBE-010)
- A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
- A MULTICOHORT, OPEN LABEL, PHASE 2 STUDY OF BOTENSILIMAB (AGEN1181) FOR TREATMENT OF ADVANCED MELANOMA REFRACTORY TO PRIOR CHECKPOINT INHIBITOR THERAPY
Data & Insights
Has run more than one trial at 175 of 367 partner sites.
Specializations
Melanoma Research
This investigator demonstrates significant expertise in treating various forms of melanoma, including both advanced metastatic ocular/uveal melanoma and resected Stage III and IV melanoma. Their research extends to investigating novel therapeutic approaches for patients with checkpoint inhibitor-refractory advanced melanoma.
- Uveal Melanoma Management
- Adjuvant Therapy in Resected Melanoma
- Refractory Melanoma Treatment
The investigator explores innovative therapeutic agents including roginolisib and botensilimab for melanoma treatment.
Head and Neck Cancer
The investigator specializes in treating locally advanced head and neck squamous cell carcinoma, with particular focus on unresected cases following chemoradiotherapy.
- Post-Chemoradiotherapy Treatment
- Advanced HNSCC Management
- Novel Therapeutic Approaches
Their research includes evaluation of novel agents like volrustomig in the treatment of head and neck cancer.
Therapeutic Innovation
The investigator focuses on evaluating novel therapeutic agents across multiple oncological conditions, with emphasis on targeted therapies and immunotherapy approaches.
- Single Agent Therapeutics
- Combination Treatment Strategies
- Post-Treatment Care
Their work encompasses both monotherapy and combination treatment approaches in advanced cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.